Literature DB >> 24651616

Impairment of aldehyde dehydrogenase-2 by 4-hydroxy-2-nonenal adduct formation and cardiomyocyte hypertrophy in mice fed a high-fat diet and injected with low-dose streptozotocin.

Vishal R Mali1, Ruizhuo Ning, Jieli Chen, Xiao-Ping Yang, Jiang Xu, Suresh S Palaniyandi.   

Abstract

Reactive aldehydes such as 4-hydroxy-2-nonenal (4HNE) are generated in the myocardium in cardiac disease. 4HNE and other toxic aldehydes form adducts with proteins, leading to cell damage and organ dysfunction. Aldehyde dehydrogenases (ALDHs) metabolize toxic aldehydes such as 4HNE into nontoxic metabolites. Both ALDH levels and activity are reduced in cardiac disease. We examined whether reduced ALDH2 activity contributes to cardiomyocyte hypertrophy in mice fed a high-fat diet and injected with low-dose streptozotocin (STZ). These mice exhibited most of the characteristics of metabolic syndrome/type-2 diabetes mellitus (DM): increased blood glucose levels depicting hyperglycemia (415.2 ± 18.7 mg/dL vs. 265.2 ± 7.6 mg/dL; P < 0.05), glucose intolerance with normal plasma insulin levels, suggesting insulin resistance and obesity as evident from increased weight (44 ± 3.1 vs. 34.50 ± 1.32 g; P < 0.05) and body fat. Myocardial ALDH2 activity was 60% lower in these mice (0.1 ± 0.012 vs. 0.04 ± 0.015 µmol/min/mg protein; P < 0.05). Myocardial 4HNE levels were also elevated in the hyperglycemic hearts. Co-immunoprecipitation study showed that 4HNE formed adducts on myocardial ALDH2 protein in the mice exhibiting metabolic syndrome/type-2 DM, and they had obvious cardiac hypertrophy compared with controls as evident from increased heart weight (HW), HW to tibial length ratio, left ventricular (LV) mass and cardiomyocyte hypertrophy. Cardiomyocyte hypertrophy was correlated inversely with ALDH2 activity (R (2 )= 0.7; P < 0.05). Finally, cardiac dysfunction was observed in mice with metabolic syndrome/type-2 DM. Therefore, we conclude that reduced ALDH2 activity may contribute to cardiac hypertrophy and dysfunction in mice presenting with some of the characteristics of metabolic syndrome/type-2 DM when on a high-fat diet and low-dose STZ injection.

Entities:  

Keywords:  4-hydroxy-2-nonenal; Aldehyde dehydrogenase 2; cardiomyocyte hypertrophy; diabetic cardiac complications; metabolic syndrome; type-2 diabetes mellitus

Mesh:

Substances:

Year:  2014        PMID: 24651616      PMCID: PMC4145606          DOI: 10.1177/1535370213520109

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  56 in total

1.  Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening.

Authors:  K Srinivasan; B Viswanad; Lydia Asrat; C L Kaul; P Ramarao
Journal:  Pharmacol Res       Date:  2005-10       Impact factor: 7.658

2.  Alterations in the diabetic myocardial proteome coupled with increased myocardial oxidative stress underlies diabetic cardiomyopathy.

Authors:  Milton Hamblin; David B Friedman; Salisha Hill; Richard M Caprioli; Holly M Smith; Michael F Hill
Journal:  J Mol Cell Cardiol       Date:  2007-01-10       Impact factor: 5.000

3.  A Glu487Lys polymorphism in the gene for mitochondrial aldehyde dehydrogenase 2 is associated with myocardial infarction in elderly Korean men.

Authors:  Sangmee Ahn Jo; Eun-Kyung Kim; Moon Ho Park; Changsu Han; Hyun-Young Park; Yangsoo Jang; Byung Joon Song; Inho Jo
Journal:  Clin Chim Acta       Date:  2007-03-24       Impact factor: 3.786

4.  Chymase inhibition reduces the progression to heart failure after autoimmune myocarditis in rats.

Authors:  Suresh S Palaniyandi; Yusuke Nagai; Kenichi Watanabe; Meilei Ma; Punniyakoti T Veeraveedu; Paras Prakash; Fadia A Kamal; Yuichi Abe; Ken'ichi Yamaguchi; Hitoshi Tachikawa; Makoto Kodama; Yoshifusa Aizawa
Journal:  Exp Biol Med (Maywood)       Date:  2007-10

5.  Mechanism of 4-HNE mediated inhibition of hDDAH-1: implications in no regulation.

Authors:  Scott P Forbes; Lawrence J Druhan; Jorge E Guzman; Narasimham Parinandi; Liwen Zhang; Kari B Green-Church; Arturo J Cardounel
Journal:  Biochemistry       Date:  2008-01-03       Impact factor: 3.162

6.  Oxidative stress and cellular stress response in diabetic nephropathy.

Authors:  Vittorio Calabrese; Cesare Mancuso; Maria Sapienza; Eduardo Puleo; Stella Calafato; Carolin Cornelius; Manuela Finocchiaro; Andrea Mangiameli; Maurizio Di Mauro; Anna Maria Giuffrida Stella; Pietro Castellino
Journal:  Cell Stress Chaperones       Date:  2007       Impact factor: 3.667

7.  Decreased complex II respiration and HNE-modified SDH subunit in diabetic heart.

Authors:  Ossama M Lashin; Pamela A Szweda; Luke I Szweda; Andrea M P Romani
Journal:  Free Radic Biol Med       Date:  2005-11-02       Impact factor: 7.376

Review 8.  Recipes for creating animal models of diabetic cardiovascular disease.

Authors:  Willa Hsueh; E Dale Abel; Jan L Breslow; Nobuyo Maeda; Richard C Davis; Edward A Fisher; Hayes Dansky; Donald A McClain; Richard McIndoe; Momtaz K Wassef; Cristina Rabadán-Diehl; Ira J Goldberg
Journal:  Circ Res       Date:  2007-05-25       Impact factor: 17.367

9.  Methylglyoxal induces advanced glycation end product (AGEs) formation and dysfunction of PDGF receptor-beta: implications for diabetic atherosclerosis.

Authors:  Anne-Valerie Cantero; Manuel Portero-Otín; Victòria Ayala; Nathalie Auge; Marie Sanson; Meyer Elbaz; Jean-Claude Thiers; Reinald Pamplona; Robert Salvayre; Anne Nègre-Salvayre
Journal:  FASEB J       Date:  2007-05-15       Impact factor: 5.191

10.  Common ALDH2 genetic variants predict development of hypertension in the SAPPHIRe prospective cohort: gene-environmental interaction with alcohol consumption.

Authors:  Yi-Cheng Chang; Yen-Feng Chiu; I-Te Lee; Low-Tone Ho; Yi-Jen Hung; Chao A Hsiung; Thomas Quertermous; Timothy Donlon; Wei-Jei Lee; Po-Chu Lee; Che-Hong Chen; Daria Mochly-Rosen; Lee-Ming Chuang
Journal:  BMC Cardiovasc Disord       Date:  2012-07-29       Impact factor: 2.298

View more
  27 in total

1.  Effect of diet-induced obesity or type 1 or type 2 diabetes on corneal nerves and peripheral neuropathy in C57Bl/6J mice.

Authors:  Matthew S Yorek; Alexander Obrosov; Hanna Shevalye; Amey Holmes; Matthew M Harper; Randy H Kardon; Mark A Yorek
Journal:  J Peripher Nerv Syst       Date:  2015-03       Impact factor: 3.494

2.  Catabolism of (2E)-4-hydroxy-2-nonenal via ω- and ω-1-oxidation stimulated by ketogenic diet.

Authors:  Zhicheng Jin; Jessica M Berthiaume; Qingling Li; Fabrice Henry; Zhong Huang; Sushabhan Sadhukhan; Peng Gao; Gregory P Tochtrop; Michelle A Puchowicz; Guo-Fang Zhang
Journal:  J Biol Chem       Date:  2014-10-01       Impact factor: 5.157

3.  Early vs. late intervention of high fat/low dose streptozotocin treated C57Bl/6J mice with enalapril, α-lipoic acid, menhaden oil or their combination: Effect on diabetic neuropathy related endpoints.

Authors:  Matthew S Yorek; Alexander Obrosov; Hanna Shevalye; Lawrence J Coppey; Randy H Kardon; Mark A Yorek
Journal:  Neuropharmacology       Date:  2016-12-23       Impact factor: 5.250

Review 4.  Alternatives to the Streptozotocin-Diabetic Rodent.

Authors:  M A Yorek
Journal:  Int Rev Neurobiol       Date:  2016-03-28       Impact factor: 3.230

Review 5.  4-Hydroxy-2-nonenal: a critical target in oxidative stress?

Authors:  Mason Breitzig; Charishma Bhimineni; Richard Lockey; Narasaiah Kolliputi
Journal:  Am J Physiol Cell Physiol       Date:  2016-07-06       Impact factor: 4.249

Review 6.  Measurement of Reactive Oxygen Species, Reactive Nitrogen Species, and Redox-Dependent Signaling in the Cardiovascular System: A Scientific Statement From the American Heart Association.

Authors:  Kathy K Griendling; Rhian M Touyz; Jay L Zweier; Sergey Dikalov; William Chilian; Yeong-Renn Chen; David G Harrison; Aruni Bhatnagar
Journal:  Circ Res       Date:  2016-07-14       Impact factor: 17.367

Review 7.  4-Hydroxy-2-nonenal, a lipid peroxidation product, as a biomarker in diabetes and its complications: challenges and opportunities.

Authors:  Deiva Dham; Bipradas Roy; Amita Gowda; Guodong Pan; Arun Sridhar; Xiangqun Zeng; Rajarajan A Thandavarayan; Suresh Selvaraj Palaniyandi
Journal:  Free Radic Res       Date:  2021-01-07

8.  Pyridostigmine Protects Against Diabetic Cardiomyopathy by Regulating Vagal Activity, Gut Microbiota, and Branched-Chain Amino Acid Catabolism in Diabetic Mice.

Authors:  Yang Yang; Ming Zhao; Xi He; Qing Wu; Dong-Ling Li; Wei-Jin Zang
Journal:  Front Pharmacol       Date:  2021-05-18       Impact factor: 5.810

9.  Normalizing glucose levels reconfigures the mammary tumor immune and metabolic microenvironment and decreases metastatic seeding.

Authors:  Heba Allah M Alsheikh; Brandon J Metge; Chae-Myeong Ha; Dominique C Hinshaw; Mateus S V Mota; Sarah C Kammerud; Tshering Lama-Sherpa; Noha Sharafeldin; Adam R Wende; Rajeev S Samant; Lalita A Shevde
Journal:  Cancer Lett       Date:  2021-05-28       Impact factor: 9.756

10.  4-Hydroxy-2-nonenal attenuates 8-oxoguanine DNA glycosylase 1 activity.

Authors:  Guodong Pan; Mandar Deshpande; Haiyan Pang; Paul M Stemmer; Nicholas J Carruthers; Colin T Shearn; Donald S Backos; Suresh S Palaniyandi
Journal:  J Cell Biochem       Date:  2020-07-06       Impact factor: 4.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.